Nanoconjugates-Based Stem Cell Therapy for the Management of COVID-19.

ABSTRACT: A potential ability of stem cells (SCs) is to regenerate and repair tissues in the human body by providing great prospects for therapeutic applications in the field of medicine. Currently, SC therapy is used in various conditions like diabetes, neurodegenerative disorders, etc. but faces some limitations like patient biocompatibility and chances of cross-infection. SCs are further modulated with nanoconjugates to overcome such challenges and will offer an advantage in the treatment of COVID-19. This pandemic requires design and development of proper treatment to save the life of human beings. Advancements in SC-based nanoconjugated therapy will open new avenues and create a significant impact in the development of futuristic nanomedicine. It may also emerge as a potential therapy for the m

SUBMITTER: Desai D 

PROVIDER: S-EPMC7648659 | biostudies-literature | 2021 Feb

REPOSITORIES: biostudies-literature